Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins
I Wiegratz, C Jung-Hoffmann, H Kuhl - Contraception, 1995 - Elsevier
The effect of a triphasic oral contraceptive containing ethinylestradiol and gestodene
(EE/GSD) on various serum hormonal parameters was compared with that of a monophasic …
(EE/GSD) on various serum hormonal parameters was compared with that of a monophasic …
Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
MR Lepot, UJ Gaspard - International Journal of Fertility, 1987 - europepmc.org
A well-known triphasic oral contraceptive (OC) containing ethinyl estradiol (EE) plus
levonorgestrel (LNG) was compared with a triphasic containing the same dose of EE in …
levonorgestrel (LNG) was compared with a triphasic containing the same dose of EE in …
The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women
CMH Coenen, JMG Hollanders, R Rolland… - … European Journal of …, 1996 - Taylor & Francis
Objective In women who use oral contraceptives with low estrogen doses, a quiescent
endometrium is frequently produced. Further reduction of the estrogen dose would not be …
endometrium is frequently produced. Further reduction of the estrogen dose would not be …
Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial
S Palacios, L Wildt, S Parke, A Machlitt, T Römer… - European Journal of …, 2010 - Elsevier
OBJECTIVE: A novel oral contraceptive (OC) that contains oestradiol valerate (E2V; 1mg of
E2V is equivalent to 0.76 mg of 17beta-oestradiol) and dienogest (DNG) has been …
E2V is equivalent to 0.76 mg of 17beta-oestradiol) and dienogest (DNG) has been …
Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on …
J Hammerstein, E Daume, A Simon, UH Winkler… - Contraception, 1993 - Elsevier
A randomized controlled clinical trial was undertaken over a 6-month treatment period with
two low-dose combined oral contraceptives (OC) to investigate whether the metabolism and …
two low-dose combined oral contraceptives (OC) to investigate whether the metabolism and …
Desogestrel, norgestimate, and gestodene: the newer progestins
B Kaplan - Annals of Pharmacotherapy, 1995 - journals.sagepub.com
Objective: To review and compare the newer progestins desogestrel, norgestimate, and
gestodene with regard to chemistry, pharmacokinetics, efficacy, and tolerability. Data …
gestodene with regard to chemistry, pharmacokinetics, efficacy, and tolerability. Data …
A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives
U Aden, C Jung-Hoffmann, H Kuhl - Contraception, 1998 - Elsevier
The effect of two triphasic oral contraceptives (Triquilar®[TRQ] and Trisiston®[TRS])
containing ethinyl estradiol (EE) and levonorgestrel (LNG) on various hormonal parameters …
containing ethinyl estradiol (EE) and levonorgestrel (LNG) on various hormonal parameters …
A comparative study of the effects of gestodene 60 µg/ethinylestradiol 15 µg and desogestrel 150 µg/ethinylestradiol 20 µg on hemostatic balance, blood lipid levels …
MJ Van der Mooren, C Klipping… - … European Journal of …, 1999 - Taylor & Francis
Objectives: This multicenter, randomized, parallel-group, open-label study was conducted to
compare the effects of gestodene (GTD) 60 µg/ethinylestradiol (EE) 15 µg and desogestrel …
compare the effects of gestodene (GTD) 60 µg/ethinylestradiol (EE) 15 µg and desogestrel …